Cargando…
High Interleukin-8 Levels Associated With Decreased Survival in Patients With Cirrhosis Following Transjugular Intrahepatic Portosystemic Shunt
BACKGROUND: Serum cytokines—reflecting systemic inflammation has been associated with the risk of decompensation and mortality in patients with cirrhosis. However, the role of systemic inflammation in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt procedure remains...
Autores principales: | Liu, Guofeng, Wang, Xiaoze, Yang, Tingting, Yan, Yuling, Xiang, Tong, Yang, Li, Luo, Xuefeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918632/ https://www.ncbi.nlm.nih.gov/pubmed/35295601 http://dx.doi.org/10.3389/fmed.2022.829245 |
Ejemplares similares
-
Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020
por: Horhat, Adelina, et al.
Publicado: (2021) -
Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update
por: Rajesh, Sasidharan, et al.
Publicado: (2020) -
Parallel Shunt for the Treatment of Transjugular Intrahepatic Portosystemic Shunt Dysfunction
por: Luo, Xuefeng, et al.
Publicado: (2013) -
Effect of splenectomy on the outcomes in patients with cirrhosis receiving transjugular intrahepatic portosystemic shunt
por: Yang, Chongtu, et al.
Publicado: (2021) -
The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips
por: Fanelli, Fabrizio
Publicado: (2014)